Quethera Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $111M
Latest Deal Amount

Quethera General Information

Description

Developer of gene therapy technologies designed to improve the future treatment of common blinding eye diseases. The company's technologies focus on the development of therapies that reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve, enabling patients to get efficient treatment for their eye diseases and recover faster.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • The Babraham Institute, Babraham Hall House
  • Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Quethera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 10-Aug-2018 $111M 00000 00000 Completed Generating Revenue
3. Grant 07-Mar-2016 00000 00000 Completed Startup
2. Early Stage VC 07-Aug-2015 $625K $625K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Quethera’s complete valuation and funding history, request access »

Quethera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view Quethera’s complete cap table history, request access »

Quethera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of gene therapy technologies designed to improve the future treatment of common blinding eye diseases. The com
Biotechnology
Cambridge, United Kingdom
00000
0000 0000-00-00
000000&0 00000

0000 000

eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000 000000000
London, United Kingdom
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

0000000

t nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt
0000 000000000
Cambridge, United Kingdom
00 As of 0000
00.000
0.000 0000-00-00
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quethera Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MiNA Therapeutics Venture Capital-Backed London, United Kingdom 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed Cambridge, United Kingdom 00 00.000 0000000000 0 00.000
0000000000000 Venture Capital-Backed Charlottesville, VA 0 000.00 0000000000 0 000.00
0000000 000000 Formerly VC-backed Redwood City, CA 00 00000 00000000 00000
000 000000000000 Venture Capital-Backed Ann Arbor, MI 0 000.00 00000000000 000.00
You’re viewing 5 of 13 competitors. Get the full list »

Quethera Executive Team (2)

Name Title Board Seat Contact Info
Keith Martin Chief Scientific Officer
Peter Widdowson Ph.D Co-Founder, Board Member & Chief Executive Officer
To view Quethera’s complete executive team members history, request access »

Quethera Board Members (3)

Name Representing Role Since
Peter Widdowson Ph.D Self Co-Founder, Board Member & Chief Executive Officer 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Quethera Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Babraham Bioscience Technologies Accelerator/Incubator 000 0000 000000 0
Cambridge Enterprise Angel Group Minority 000 0000 000000 0
Midven Venture Capital Minority 000 0000 000000 0
Parkwalk Advisors Venture Capital Minority 000 0000 000000 0
UK Innovation & Science Seed Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »